MUMBAI, India, May 29 -- Intellectual Property India has published a patent application (202641062334 A) filed by Adichunchanagiri University; and Adichunchanagiri Institute Of Medical Sciences, Mandya, Karnataka, on May 16, for 'utility of hba1c, ankle-brachial pressure index and doppler scan to predict amputation in diabetic foot.'
Inventor(s) include Dr. Abhishek Mahaling; and Dr. M A Balakrishna.
The application for the patent was published on May 29, under issue no. 22/2026.
According to the abstract released by the Intellectual Property India: "Diabetes mellitus often leads to serious foot complications, including ulcers and poor blood flow to the legs, which can result in slow healing, infections, and even amputations. This study explored how glycated hemoglobin (HbA1c) levels relate to the severity of peripheral arterial disease (PAD) and wound outcomes in patients with diabetic foot problems. It also examined the usefulness of Ankle-Brachial Pressure Index (ABPI) and arterial Doppler ultrasound alongside HbA1c for predicting amputation risk. [0019] A total of 87 patients were assessed over 18 months. Most had poor blood sugar control, with over half showing HbA1c above 9%. Higher HbA1c levels were clearly linked to worse arterial disease, lower ABPI values, more severe ulcers according to Wagner grading, and higher chances of delayed healing or amputation. The study confirms that combining HbA1c monitoring with vascular assessments provides valuable information for early risk identification and better management of diabetic foot complications."
Disclaimer: Curated by HT Syndication.
